Lucentis® is the brand name for ranibizumab, a drug injected into the eye to slow vision loss in people who have “wet” age-related macular degeneration (AMD). Lucentis is part of a class of drugs that block the growth of abnormal blood vessels, which is the cause of wet AMD. Lucentis was designed specifically as a treatment for wet AMD.
Another drug, Avastin® (bevacizumab), is chemically similar to Lucentis. Based on a study funded by the National Eye Institute (NEI), a part of the federal National Institutes of Health (NIH), the two drugs have equal effect on visual acuity.
Next Page: How Does Lucentis® Work?
Related Resources
Related Topics
Related Topics
Related Answers
Related Answers
